SCI's Daily Digest: your one-stop shop for all of the day's news in science based industry
In today's Daily Digest, drug safety regulator to pilot its own genetic biobank, £650 million funding to the life science sector, and more.
The UK government is providing £650 million in funding to the life science sector in a move to ‘drive forward [the] government’s priority to grow the economy.’ The government said that the so-called 'Life Sci for Growth' package brings together ten different policies and includes new money for innovation to prepare for future health emergencies.
The Life Sciences Council, a group of UK government ministers and global life science industry leaders, met on 25 May to discuss how the UK can unlock the economic potential of the sector and address recent declines in clinical trials performance, and investment. The meeting included the UK Chancellor and AstraZeneca’s CEO.
The UK’s Prime Minister met with the CEOs from OpenAI, Google DeepMind and Anthropic to discuss joint action to ensure the development of safe and responsible AI and how to establish the right approach to governance.
The UK’s Medicines and Healthcare products Regulatory Authority (MHRA) has said that it will be the first drug safety regulator in the world to pilot its own genetic biobank. It will focus on understanding how a patient’s genetic makeup can impact the safety of their medicines.
The UK government has provided a response to the former Business Energy and Industrial Strategy Committee’s report on the semiconductor industry in the UK. An initial response to the report has been deemed inadequate by the committee.
The US Department of Energy has launched the Clean Fuels & Products ShotTM, an initiative that aims to reduce greenhouse gas emissions, supporting the US’s goal of reaching net zero by 2050.